Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 298 | 243 | 47 | 366 | 987 |
| Receivables | 355 | 140 | 935 | 1,070 | 890 |
| Inventories | 147 | 189 | 312 | 293 | 268 |
| TOTAL | $870 | $667 | $1,403 | $1,777 | $2,235 |
| Non-Current Assets | |||||
| PPE Net | 12 | 14 | 16 | 19 | 21 |
| Other Non-Current Assets | 2,000 | 2,056 | 2,109 | 2,160 | 2,093 |
| TOTAL | $2,012 | $2,070 | $2,125 | $2,179 | $2,114 |
| Total Assets | $2,882 | $2,737 | $3,528 | $3,956 | $4,349 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 786 | 1,387 | 2,388 | 1,869 | 1,598 |
| Accrued Expenses | 200 | 507 | 321 | 179 | 170 |
| TOTAL | $1,689 | $3,902 | $3,416 | $2,752 | $2,442 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 703 | 708 | 707 | 704 | 674 |
| TOTAL | $352 | $531 | $707 | $881 | $1,010 |
| Total Liabilities | $2,041 | $4,433 | $4,123 | $3,633 | $3,452 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,998 | 1,350 | 1,336 | 1,292 | 1,290 |
| Common Shares | 18 | 12 | 12 | 11 | 11 |
| Retained earnings | -99,442 | -98,772 | -97,530 | -96,432 | -95,579 |
| Other shareholders' equity | 74 | 76 | 76 | 56 | 39 |
| TOTAL | $841 | $-1,696 | $-595 | $323 | $897 |
| Total Liabilities And Equity | $2,882 | $2,737 | $3,528 | $3,956 | $4,349 |